XML 29 R18.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Goodwill and intangible assets | 12 Months Ended
--- | ---
Dec. 30, 2017
Goodwill And Intangible Assets Disclosure [Abstract] |
Goodwill Disclosure [Text Block] | 11. Goodwill and Intangible Assets
|  |  |  |  | December 30, 2017 | December 31, 2016
|  |  |  |  | $ | $
Goodwill |  | 109,533 | 223,611
Intangible assets with a finite life at cost, less accumulated |  |
| amortization of $41,036 (December 31, 2016 - $30,989) | 172,059 | 183,524
The following is a summary of changes in goodwill:
|  |  |  | Global Ingredients | Consumer Products | Total
|  |  |  | $ | $ | $
Balance at January 2, 2016 | 25,990 | 215,700 | 241,690
| Goodwill impairment(1) | (17,540) | - | (17,540)
| Foreign exchange | (195) | (344) | (539)
Balance at December 31, 2016 | 8,255 | 215,356 | 223,611
| Goodwill impairment(2) | - | (115,000) | (115,000)
| Foreign exchange | 922 | - | 922
Balance at December 30, 2017 | 9,177 | 100,356 | 109,533
(1) Based on the results of the annual impairment test performed for the year ended December 31, 2016, the Company determined that the carrying value of the goodwill associated with the Sunflower reporting unit of the Raw Material Sourcing and Supply operating segment exceeded its implied fair value, reflecting lower anticipated sales demand and higher ex pected production and capital costs as a result of the sunflower recall. As a result, the Company recognized a goodwill impairment charge of $17.5 mi llion in 2016. (2) Based on the results of the annual impairment test performed for the year ended December 30, 2017, the Company determined that the carrying value of the Healthy Fruit reporting unit of the Consumer Products operating segment exceeded its fair value, reflecting lower-than-expected sales and operating performance for frozen fruit since the Sunr ise Acquisition, and uncertainty of future sales due to lost customer volumes and declining consumer consumption trends in 2017. As a result, the Company recognized a goodwill impairment charge of $115.0 million in 2017. The major components of intangible assets as at December 30, 2017 and December 31, 2016 were as follows:
|  |  |  | December 30, 2017
|  |  |  | Cost | Accumulated amortization | Net book value
|  |  |  | $ | $ | $
Customer relationships | 211,176 | 39,274 | 171,902
Patents, trademarks and other | 1,919 | 1,762 | 157
|  |  |  | 213,095 | 41,036 | 172,059
|  |  |  | December 31, 2016
|  |  |  | Cost | Accumulated amortization | Net book value
|  |  |  | $ | $ | $
Customer relationships | 212,172 | 28,914 | 183,258
Patents, trademarks and other | 2,341 | 2,075 | 266
|  |  |  | 214,513 | 30,989 | 183,524
The following is a summary of changes in intangible assets:
|  |  |  |  | Customer | Patents, trademarks |
|  |  |  |  | relationships | and other | Total
|  |  |  |  | $ | $ | $
Balance at January 2, 2016 |  | 194,633 | 375 | 195,008
| Amortization |  | (11,166) | (116) | (11,282)
| Foreign exchange |  | (209) | 7 | (202)
Balance at December 31, 2016 |  | 183,258 | 266 | 183,524
| Impairment(1) |  | (456) | - | (456)
| Amortization |  | (11,086) | (109) | (11,195)
| Foreign exchange |  | 186 | - | 186
Balance at December 30, 2017 |  | 171,902 | 157 | 172,059
(1) Represents impairment of customer relationship intangible asset related to the exited nutrition bar product lines (see note 4). The Company estimates that the aggregate future amortization expense associated with finite-life intangible assets in each of the next five fiscal years and thereafter will be as follows:
|  |  |  |  | $
2018 |  | 11,135
2019 |  | 11,021
2020 |  | 10,324
2021 |  | 10,112
2022 |  | 10,112
Thereafter |  | 119,355
|  | 172,059

X
- References No definition available. + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for the aggregate amount of goodwill and a description of intangible assets, which may include (a) for amortizable intangible assets (also referred to as finite-lived intangible assets), the carrying amount, the amount of any significant residual value, and the weighted-average amortization period, (b) for intangible assets not subject to amortization (also referred to as indefinite-lived intangible assets), the carrying amount, and (c) the amount of research and development assets acquired and written off in the period, including the line item in the income statement in which the amounts written off are aggregated, if not readily apparent from the income statement. Also discloses (a) for amortizable intangibles assets in total and by major class, the gross carrying amount and accumulated amortization, the total amortization expense for the period, and the estimated aggregate amortization expense for each of the five succeeding fiscal years, (b) for intangible assets not subject to amortization the carrying amount in total and by major class, and (c) for goodwill, in total and for each reportable segment, the changes in the carrying amount of goodwill during the period (including the aggregate amount of goodwill acquired, the aggregate amount of impairment losses recognized, and the amount of goodwill included in the gain (loss) on disposal of a reporting unit). If any part of goodwill has not been allocated to a reportable segment, discloses the unallocated amount and the reasons for not allocating. For each impairment loss recognized related to an intangible asset (excluding goodwill), discloses: (a) a description of the impaired intangible asset and the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method for determining fair value, (c) the caption in the income statement or the statement of activities in which the impairment loss is aggregated, and (d) the segment in which the impaired intangible asset is reported. For each goodwill impairment loss recognized, discloses: (a) a description of the facts and circumstances leading to the impairment, (b) the amount of the impairment loss and the method of determining the fair value of the associated reporting unit, and (c) if a recognized impairment loss is an estimate not finalized and the reasons why the estimate is not final. May also disclose the nature and amount of any significant adjustments made to a previous estimate of an impairment loss. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -URI http://asc.fasb.org/topic&trid=2144416 + Details
Name: | us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration